bioAffinity Technologies attends Battle of the Blues lung cancer event
BIAF•bioAffinity Technologies will attend the Lung Cancer Initiative of North Carolina's Battle of the Blues on Nov. 5, 2026, where its noninvasive CyPath Lung test will be highlighted alongside other lung cancer diagnostics and therapies.
1. Event participation
bioAffinity Technologies will attend the Lung Cancer Initiative of North Carolina's Battle of the Blues on Nov. 5, 2026. The event will highlight lung cancer diagnostics and therapies, including the company's noninvasive CyPath Lung test for early detection.
